Contact Us

NuNeruve’s priority areas
for therapautic application:


NuNerve Pty Limited is focused on the development of novel technologies for the treatment or prevention of progressive neurodegenerative diseases, particularly motor neuron disease and Alzheimer’s disease.

NuNerve’s research and development portfolio centres on biotechnologies that stimulate neurogenesis - the creation of new brain cells from neural stem cells. By enhancing the brain’s innate capacity to regenerate damaged or dying neurons we hope to slow or prevent neural degeneration.